

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.33180833 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.41987540 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.41987540 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 5.00762405 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.00315532 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.95458290 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.95458290 |
| 8 | positive regulation of interferon-alpha production (GO:0032727) | 4.83060713 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.63026898 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.63026898 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.63026898 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 4.63026898 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.63026898 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.63026898 |
| 15 | regulation of interferon-alpha production (GO:0032647) | 4.60985752 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.49756524 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.46497431 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.45558520 |
| 19 | detection of bacterium (GO:0016045) | 4.42928741 |
| 20 | type I interferon signaling pathway (GO:0060337) | 4.26643860 |
| 21 | cellular response to type I interferon (GO:0071357) | 4.26643860 |
| 22 | response to peptidoglycan (GO:0032494) | 4.24361967 |
| 23 | response to type I interferon (GO:0034340) | 4.23946118 |
| 24 | respiratory burst (GO:0045730) | 4.19499658 |
| 25 | detection of external biotic stimulus (GO:0098581) | 4.03680747 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 4.02965390 |
| 27 | regulation of gamma-delta T cell activation (GO:0046643) | 4.02950376 |
| 28 | cellular response to interferon-beta (GO:0035458) | 4.00322566 |
| 29 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.00030560 |
| 30 | positive regulation of antigen processing and presentation (GO:0002579) | 3.86453820 |
| 31 | response to interferon-beta (GO:0035456) | 3.84736450 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 3.81925758 |
| 33 | response to interferon-alpha (GO:0035455) | 3.80835808 |
| 34 | granulocyte activation (GO:0036230) | 3.78960209 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.76847538 |
| 36 | neutrophil activation (GO:0042119) | 3.72729201 |
| 37 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.70775569 |
| 38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.69607843 |
| 39 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.66865603 |
| 40 | cellular response to exogenous dsRNA (GO:0071360) | 3.66679878 |
| 41 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.65596618 |
| 42 | regulation of tolerance induction (GO:0002643) | 3.65414594 |
| 43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.60310318 |
| 44 | detection of biotic stimulus (GO:0009595) | 3.59784766 |
| 45 | defense response to protozoan (GO:0042832) | 3.59606908 |
| 46 | positive regulation of B cell differentiation (GO:0045579) | 3.59172779 |
| 47 | regulation of RIG-I signaling pathway (GO:0039535) | 3.49779412 |
| 48 | natural killer cell mediated immunity (GO:0002228) | 3.48684517 |
| 49 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.48684517 |
| 50 | myeloid cell activation involved in immune response (GO:0002275) | 3.48266242 |
| 51 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.47099401 |
| 52 | B cell mediated immunity (GO:0019724) | 3.46762789 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.45997690 |
| 54 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.45213067 |
| 55 | positive regulation of interferon-beta production (GO:0032728) | 3.42423620 |
| 56 | negative regulation of viral genome replication (GO:0045071) | 3.41824163 |
| 57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.39857493 |
| 58 | myeloid dendritic cell activation (GO:0001773) | 3.39665384 |
| 59 | cellular extravasation (GO:0045123) | 3.39304711 |
| 60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.37391581 |
| 61 | response to host immune response (GO:0052572) | 3.37391581 |
| 62 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.35184124 |
| 63 | positive thymic T cell selection (GO:0045059) | 3.34531870 |
| 64 | reactive oxygen species biosynthetic process (GO:1903409) | 3.33604871 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.33359124 |
| 66 | negative T cell selection (GO:0043383) | 3.32853373 |
| 67 | regulation of antigen processing and presentation (GO:0002577) | 3.30568542 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.30139381 |
| 69 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.28357063 |
| 70 | negative thymic T cell selection (GO:0045060) | 3.26089604 |
| 71 | positive regulation of mast cell activation (GO:0033005) | 3.25970986 |
| 72 | cellular response to zinc ion (GO:0071294) | 3.24462115 |
| 73 | response to protozoan (GO:0001562) | 3.24315821 |
| 74 | response to muramyl dipeptide (GO:0032495) | 3.23811946 |
| 75 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.23230857 |
| 76 | T cell migration (GO:0072678) | 3.23151447 |
| 77 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.22677239 |
| 78 | regulation of mast cell degranulation (GO:0043304) | 3.21808728 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 3.20072646 |
| 80 | regulation of regulatory T cell differentiation (GO:0045589) | 3.19944246 |
| 81 | myeloid dendritic cell differentiation (GO:0043011) | 3.19840579 |
| 82 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.19682367 |
| 83 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18755059 |
| 84 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.18438699 |
| 85 | superoxide anion generation (GO:0042554) | 3.17571548 |
| 86 | leukocyte mediated cytotoxicity (GO:0001909) | 3.16438391 |
| 87 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.15298396 |
| 88 | positive regulation of type 2 immune response (GO:0002830) | 3.14046931 |
| 89 | lymphocyte chemotaxis (GO:0048247) | 3.13866718 |
| 90 | response to interleukin-15 (GO:0070672) | 3.13212434 |
| 91 | positive regulation of tolerance induction (GO:0002645) | 3.11384203 |
| 92 | regulation of chemokine biosynthetic process (GO:0045073) | 3.07837614 |
| 93 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.05548488 |
| 94 | regulation of B cell differentiation (GO:0045577) | 3.05294583 |
| 95 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.05138816 |
| 96 | response to host (GO:0075136) | 3.05138816 |
| 97 | response to host defenses (GO:0052200) | 3.05138816 |
| 98 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.04515403 |
| 99 | T-helper 1 type immune response (GO:0042088) | 3.03047868 |
| 100 | positive regulation of lymphocyte migration (GO:2000403) | 3.03010305 |
| 101 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.01881405 |
| 102 | regulation of mast cell activation (GO:0033003) | 3.00848832 |
| 103 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.00799950 |
| 104 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.99010247 |
| 105 | positive T cell selection (GO:0043368) | 2.96378111 |
| 106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95349816 |
| 107 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.94820336 |
| 108 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.93795027 |
| 109 | positive regulation of mast cell degranulation (GO:0043306) | 2.93795027 |
| 110 | response to interferon-gamma (GO:0034341) | 2.92897535 |
| 111 | cellular response to interleukin-15 (GO:0071350) | 2.92680955 |
| 112 | mast cell activation (GO:0045576) | 2.92525466 |
| 113 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.91793672 |
| 114 | negative regulation of interleukin-17 production (GO:0032700) | 2.91253963 |
| 115 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.90709624 |
| 116 | T cell selection (GO:0045058) | 2.88870989 |
| 117 | dendritic cell differentiation (GO:0097028) | 2.88046058 |
| 118 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.87175769 |
| 119 | myeloid leukocyte activation (GO:0002274) | 2.87143968 |
| 120 | positive regulation of defense response to virus by host (GO:0002230) | 2.86645689 |
| 121 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.86503202 |
| 122 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.86503202 |
| 123 | B cell receptor signaling pathway (GO:0050853) | 2.85928249 |
| 124 | cellular response to interferon-gamma (GO:0071346) | 2.85517632 |
| 125 | positive regulation of interleukin-12 production (GO:0032735) | 2.84495443 |
| 126 | positive regulation of T cell migration (GO:2000406) | 2.84373562 |
| 127 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82979719 |
| 128 | neutrophil mediated immunity (GO:0002446) | 2.82880807 |
| 129 | detection of other organism (GO:0098543) | 2.82092666 |
| 130 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.80734850 |
| 131 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.80599177 |
| 132 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.80393302 |
| 133 | dendritic cell chemotaxis (GO:0002407) | 2.79740217 |
| 134 | leukocyte aggregation (GO:0070486) | 2.77208888 |
| 135 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.77117302 |
| 136 | positive regulation of isotype switching (GO:0045830) | 2.75142350 |
| 137 | macrophage activation (GO:0042116) | 2.74974960 |
| 138 | microglial cell activation (GO:0001774) | 2.72800459 |
| 139 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.72009131 |
| 140 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.71895645 |
| 141 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.70675081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.05561295 |
| 2 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.26093878 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.34274354 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.71764652 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.57367274 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.10582507 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.77635112 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.59143319 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.55318436 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.48420576 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.29665679 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.11010321 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.07039933 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.94180565 |
| 15 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.85078726 |
| 16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.79101480 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.67668217 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.65929534 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.40960190 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31133763 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18889984 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.17837857 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.16143293 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.10685111 |
| 25 | MYB_26560356_Chip-Seq_TH2_Human | 2.04619795 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.99044911 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95338963 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91972073 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91272377 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.89493384 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.82648598 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.80248020 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77644130 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75521678 |
| 35 | MAF_26560356_Chip-Seq_TH1_Human | 1.75404809 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.71698931 |
| 37 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.71367224 |
| 38 | MYB_26560356_Chip-Seq_TH1_Human | 1.70263466 |
| 39 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68581643 |
| 40 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63792938 |
| 41 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.62194685 |
| 42 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56661953 |
| 43 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56560514 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55861755 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.51739255 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51735794 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49761596 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48809139 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.46515954 |
| 50 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41633113 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37436176 |
| 52 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33762474 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.31283949 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30202719 |
| 55 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28917438 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24013938 |
| 57 | UTX_26944678_Chip-Seq_JUKART_Human | 1.21641789 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.19668780 |
| 59 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16253884 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.15160125 |
| 61 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14625295 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12523876 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12260062 |
| 64 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11168451 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10619702 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.10061445 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08378489 |
| 68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06658624 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04217807 |
| 70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04170624 |
| 71 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02554506 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02013979 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00411721 |
| 74 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99016803 |
| 75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97061927 |
| 76 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95127507 |
| 77 | MAF_26560356_Chip-Seq_TH2_Human | 0.94083012 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94069106 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.93844177 |
| 80 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.93752758 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91483138 |
| 82 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.90162227 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89532737 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89272362 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.86341416 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.85051314 |
| 87 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84732022 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.83808664 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.82818535 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82336539 |
| 91 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81943782 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.81729034 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81716150 |
| 94 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81317692 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79305249 |
| 96 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.78215252 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.77879623 |
| 98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76798479 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.76380293 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75687329 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75142832 |
| 102 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.73457405 |
| 103 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72361329 |
| 104 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.71021248 |
| 105 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.69238581 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69230449 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.68265614 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67691523 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.67607860 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.66534954 |
| 111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.66491756 |
| 112 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.64956244 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.64362681 |
| 114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.64306218 |
| 115 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63584830 |
| 116 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.63460678 |
| 117 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.61144150 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.60242708 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59541952 |
| 120 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.58895443 |
| 121 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.58298477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.23979382 |
| 2 | * MP0009785_altered_susceptibility_to | 3.72315098 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.53634919 |
| 4 | MP0003436_decreased_susceptibility_to | 3.46960425 |
| 5 | * MP0005025_abnormal_response_to | 3.13583828 |
| 6 | * MP0005000_abnormal_immune_tolerance | 3.13175200 |
| 7 | MP0005671_abnormal_response_to | 3.12255915 |
| 8 | MP0000685_abnormal_immune_system | 3.10847474 |
| 9 | * MP0002419_abnormal_innate_immunity | 3.00071414 |
| 10 | MP0003724_increased_susceptibility_to | 2.98765036 |
| 11 | MP0001790_abnormal_immune_system | 2.89392089 |
| 12 | MP0005387_immune_system_phenotype | 2.89392089 |
| 13 | MP0006082_CNS_inflammation | 2.81326271 |
| 14 | MP0001800_abnormal_humoral_immune | 2.78475679 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.73150211 |
| 16 | * MP0002723_abnormal_immune_serum | 2.59726201 |
| 17 | * MP0001819_abnormal_immune_cell | 2.41468714 |
| 18 | MP0003303_peritoneal_inflammation | 2.40684493 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.39184267 |
| 20 | MP0004510_myositis | 2.23542764 |
| 21 | MP0004947_skin_inflammation | 2.13061555 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.10247445 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.08129778 |
| 24 | MP0002006_tumorigenesis | 2.06051387 |
| 25 | * MP0010155_abnormal_intestine_physiology | 2.05226008 |
| 26 | MP0002405_respiratory_system_inflammati | 2.04309646 |
| 27 | MP0001853_heart_inflammation | 2.01859037 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.01698130 |
| 29 | * MP0001845_abnormal_inflammatory_respons | 1.90585124 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.89506074 |
| 31 | MP0000716_abnormal_immune_system | 1.85853657 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.81242610 |
| 33 | MP0002398_abnormal_bone_marrow | 1.80549421 |
| 34 | MP0002254_reproductive_system_inflammat | 1.80317004 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.73917295 |
| 36 | MP0005310_abnormal_salivary_gland | 1.70397134 |
| 37 | * MP0008469_abnormal_protein_level | 1.66362826 |
| 38 | MP0008260_abnormal_autophagy | 1.65211621 |
| 39 | MP0001873_stomach_inflammation | 1.63685632 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.57008969 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.52770566 |
| 42 | MP0003763_abnormal_thymus_physiology | 1.52509162 |
| 43 | * MP0009764_decreased_sensitivity_to | 1.51752451 |
| 44 | MP0000343_altered_response_to | 1.51588020 |
| 45 | MP0002429_abnormal_blood_cell | 1.51471368 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.47006706 |
| 47 | * MP0003448_altered_tumor_morphology | 1.44283498 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.43260893 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.43260893 |
| 50 | MP0002722_abnormal_immune_system | 1.41183646 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.36611245 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.35824958 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.31589484 |
| 54 | MP0004782_abnormal_surfactant_physiolog | 1.31495279 |
| 55 | MP0003866_abnormal_defecation | 1.31092387 |
| 56 | MP0003191_abnormal_cellular_cholesterol | 1.28450349 |
| 57 | MP0005451_abnormal_body_composition | 1.27529387 |
| 58 | MP0000490_abnormal_crypts_of | 1.27214907 |
| 59 | MP0009278_abnormal_bone_marrow | 1.25879500 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.25680483 |
| 61 | MP0000604_amyloidosis | 1.25131334 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.22628891 |
| 63 | * MP0000858_altered_metastatic_potential | 1.22535308 |
| 64 | * MP0003075_altered_response_to | 1.21982689 |
| 65 | MP0004883_abnormal_blood_vessel | 1.13798129 |
| 66 | MP0003183_abnormal_peptide_metabolism | 1.10602756 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.10132078 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.09478187 |
| 69 | MP0002132_abnormal_respiratory_system | 1.08994051 |
| 70 | MP0008004_abnormal_stomach_pH | 1.07294754 |
| 71 | MP0010307_abnormal_tumor_latency | 1.03570754 |
| 72 | MP0009840_abnormal_foam_cell | 1.00776397 |
| 73 | * MP0005166_decreased_susceptibility_to | 0.99268251 |
| 74 | MP0000015_abnormal_ear_pigmentation | 0.92830200 |
| 75 | MP0001663_abnormal_digestive_system | 0.92659033 |
| 76 | MP0004381_abnormal_hair_follicle | 0.91626324 |
| 77 | MP0003186_abnormal_redox_activity | 0.91061153 |
| 78 | * MP0009763_increased_sensitivity_to | 0.88452396 |
| 79 | MP0005164_abnormal_response_to | 0.87338648 |
| 80 | MP0003045_fibrosis | 0.82861432 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 0.82467750 |
| 82 | MP0001851_eye_inflammation | 0.82191824 |
| 83 | MP0000703_abnormal_thymus_morphology | 0.81505971 |
| 84 | MP0005390_skeleton_phenotype | 0.81112090 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.80387355 |
| 86 | MP0003828_pulmonary_edema | 0.80019395 |
| 87 | MP0001348_abnormal_lacrimal_gland | 0.79888531 |
| 88 | MP0002933_joint_inflammation | 0.78130764 |
| 89 | MP0002139_abnormal_hepatobiliary_system | 0.77466488 |
| 90 | MP0009765_abnormal_xenobiotic_induced | 0.74366687 |
| 91 | MP0000249_abnormal_blood_vessel | 0.72075821 |
| 92 | MP0005360_urolithiasis | 0.69078194 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.66826972 |
| 94 | MP0005075_abnormal_melanosome_morpholog | 0.65190443 |
| 95 | MP0003656_abnormal_erythrocyte_physiolo | 0.64701631 |
| 96 | MP0003690_abnormal_glial_cell | 0.63798962 |
| 97 | MP0003795_abnormal_bone_structure | 0.62577165 |
| 98 | MP0000920_abnormal_myelination | 0.61062940 |
| 99 | * MP0002136_abnormal_kidney_physiology | 0.60944735 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.60242706 |
| 101 | MP0006054_spinal_hemorrhage | 0.56778890 |
| 102 | MP0008874_decreased_physiological_sensi | 0.56543693 |
| 103 | MP0005085_abnormal_gallbladder_physiolo | 0.55632875 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.55274703 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.54183379 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53973706 |
| 107 | MP0001216_abnormal_epidermal_layer | 0.53814478 |
| 108 | MP0000371_diluted_coat_color | 0.53154020 |
| 109 | MP0001881_abnormal_mammary_gland | 0.53121385 |
| 110 | MP0000609_abnormal_liver_physiology | 0.53024406 |
| 111 | MP0002095_abnormal_skin_pigmentation | 0.52429326 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.50834119 |
| 113 | MP0008873_increased_physiological_sensi | 0.50754381 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.49880101 |
| 115 | MP0001191_abnormal_skin_condition | 0.49135801 |
| 116 | MP0005535_abnormal_body_temperature | 0.48885019 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.48665747 |
| 118 | MP0000477_abnormal_intestine_morphology | 0.46748075 |
| 119 | MP0005023_abnormal_wound_healing | 0.45404455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.54542434 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.12604602 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.06505465 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.97541592 |
| 5 | Autoimmune thrombocytopenia (HP:0001973) | 4.70648987 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.70185412 |
| 7 | Myositis (HP:0100614) | 4.66188081 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.41225136 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 4.25454281 |
| 10 | Recurrent skin infections (HP:0001581) | 4.08906063 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.02410142 |
| 12 | Orchitis (HP:0100796) | 3.90272387 |
| 13 | Recurrent viral infections (HP:0004429) | 3.85534521 |
| 14 | Chronic otitis media (HP:0000389) | 3.77954406 |
| 15 | T lymphocytopenia (HP:0005403) | 3.75110802 |
| 16 | Vacuolated lymphocytes (HP:0001922) | 3.71031028 |
| 17 | Optic neuritis (HP:0100653) | 3.57899807 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.57899807 |
| 19 | Vasculitis (HP:0002633) | 3.55629594 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.48644622 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.48644622 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 3.45287099 |
| 23 | Obstructive lung disease (HP:0006536) | 3.45287099 |
| 24 | Gingivitis (HP:0000230) | 3.45263441 |
| 25 | Pustule (HP:0200039) | 3.43382257 |
| 26 | Periodontitis (HP:0000704) | 3.37742625 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 3.32204260 |
| 28 | Thrombocytosis (HP:0001894) | 3.25886544 |
| 29 | Cellulitis (HP:0100658) | 3.25258622 |
| 30 | Stomatitis (HP:0010280) | 3.19032363 |
| 31 | Meningitis (HP:0001287) | 3.16420947 |
| 32 | Prostate neoplasm (HP:0100787) | 3.10912589 |
| 33 | Petechiae (HP:0000967) | 3.04831776 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 2.94717564 |
| 35 | Recurrent bronchitis (HP:0002837) | 2.94467657 |
| 36 | Gangrene (HP:0100758) | 2.86271360 |
| 37 | Abnormality of T cell physiology (HP:0011840) | 2.85201436 |
| 38 | Amyloidosis (HP:0011034) | 2.84530532 |
| 39 | Increased IgM level (HP:0003496) | 2.83297621 |
| 40 | Basal ganglia calcification (HP:0002135) | 2.80938266 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.78675665 |
| 42 | Recurrent pneumonia (HP:0006532) | 2.77607050 |
| 43 | Hypergammaglobulinemia (HP:0010702) | 2.73517197 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.73505911 |
| 45 | Urticaria (HP:0001025) | 2.71547049 |
| 46 | Abnormality of the prostate (HP:0008775) | 2.71389654 |
| 47 | Pulmonary embolism (HP:0002204) | 2.71257174 |
| 48 | IgM deficiency (HP:0002850) | 2.70820317 |
| 49 | Pulmonary infiltrates (HP:0002113) | 2.69408383 |
| 50 | Inflammation of the large intestine (HP:0002037) | 2.68577419 |
| 51 | Agammaglobulinemia (HP:0004432) | 2.68116118 |
| 52 | Autoimmune hemolytic anemia (HP:0001890) | 2.67456059 |
| 53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.65965865 |
| 54 | Recurrent lower respiratory tract infections (HP:0002783) | 2.62687446 |
| 55 | Nasal polyposis (HP:0100582) | 2.60741635 |
| 56 | Anorexia (HP:0002039) | 2.58681080 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.57862702 |
| 58 | Osteomyelitis (HP:0002754) | 2.57663965 |
| 59 | Disinhibition (HP:0000734) | 2.57632291 |
| 60 | Keratoconjunctivitis (HP:0001096) | 2.56289507 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.55955995 |
| 62 | Abnormality of the pleura (HP:0002103) | 2.50658149 |
| 63 | Colitis (HP:0002583) | 2.50642711 |
| 64 | Abnormality of T cells (HP:0002843) | 2.47728575 |
| 65 | Leukocytosis (HP:0001974) | 2.46765873 |
| 66 | Gingival bleeding (HP:0000225) | 2.45540671 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.44784410 |
| 68 | Thick nail (HP:0001805) | 2.43517314 |
| 69 | Arterial thrombosis (HP:0004420) | 2.41850672 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 2.40867618 |
| 71 | Chronic diarrhea (HP:0002028) | 2.39628403 |
| 72 | Eosinophilia (HP:0001880) | 2.39624609 |
| 73 | Malnutrition (HP:0004395) | 2.38461381 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36932034 |
| 75 | Purpura (HP:0000979) | 2.35918647 |
| 76 | Episodic fever (HP:0001954) | 2.34119615 |
| 77 | Axonal loss (HP:0003447) | 2.34056224 |
| 78 | Lymphopenia (HP:0001888) | 2.33385939 |
| 79 | Tetraparesis (HP:0002273) | 2.33296577 |
| 80 | Hemoptysis (HP:0002105) | 2.30394285 |
| 81 | Loss of speech (HP:0002371) | 2.30019035 |
| 82 | Encephalitis (HP:0002383) | 2.29781328 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.29667533 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 2.29099604 |
| 85 | Peritonitis (HP:0002586) | 2.28950488 |
| 86 | Granulocytopenia (HP:0001913) | 2.28703523 |
| 87 | Increased IgE level (HP:0003212) | 2.27085692 |
| 88 | Premature loss of primary teeth (HP:0006323) | 2.25755841 |
| 89 | Glomerulopathy (HP:0100820) | 2.25707056 |
| 90 | Polyneuropathy (HP:0001271) | 2.25463364 |
| 91 | Hematochezia (HP:0002573) | 2.23303324 |
| 92 | Glomerulonephritis (HP:0000099) | 2.20153357 |
| 93 | Panhypogammaglobulinemia (HP:0003139) | 2.18831929 |
| 94 | Skin ulcer (HP:0200042) | 2.18554624 |
| 95 | Skin rash (HP:0000988) | 2.17598040 |
| 96 | Joint swelling (HP:0001386) | 2.16869547 |
| 97 | Gastrointestinal infarctions (HP:0005244) | 2.15419931 |
| 98 | Hypochromic anemia (HP:0001931) | 2.15275013 |
| 99 | Agnosia (HP:0010524) | 2.13956906 |
| 100 | Cheilitis (HP:0100825) | 2.13771425 |
| 101 | Sepsis (HP:0100806) | 2.12886601 |
| 102 | Abnormality of T cell number (HP:0011839) | 2.11642272 |
| 103 | Dysostosis multiplex (HP:0000943) | 2.11253791 |
| 104 | Hepatosplenomegaly (HP:0001433) | 2.10792576 |
| 105 | Vertigo (HP:0002321) | 2.09984468 |
| 106 | Epistaxis (HP:0000421) | 2.08016301 |
| 107 | IgG deficiency (HP:0004315) | 2.06983402 |
| 108 | Increased serum ferritin (HP:0003281) | 2.06934755 |
| 109 | Albinism (HP:0001022) | 2.05446055 |
| 110 | Chronic sinusitis (HP:0011109) | 2.05417610 |
| 111 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.03872968 |
| 112 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.03872968 |
| 113 | Abnormality of glycolipid metabolism (HP:0010969) | 2.03872968 |
| 114 | Poikiloderma (HP:0001029) | 2.01385506 |
| 115 | Prolonged bleeding time (HP:0003010) | 2.01179171 |
| 116 | Abnormality of eosinophils (HP:0001879) | 2.00018423 |
| 117 | Abnormality of the pericardium (HP:0001697) | 1.99823400 |
| 118 | Acute hepatic failure (HP:0006554) | 1.99068337 |
| 119 | IgA deficiency (HP:0002720) | 1.95847388 |
| 120 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94311372 |
| 121 | Abnormality of iron homeostasis (HP:0011031) | 1.94235759 |
| 122 | Keratitis (HP:0000491) | 1.93719246 |
| 123 | Chest pain (HP:0100749) | 1.93266639 |
| 124 | Arthralgia (HP:0002829) | 1.90361158 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.73584637 |
| 2 | BLK | 3.52202872 |
| 3 | RIPK4 | 3.33741664 |
| 4 | IRAK4 | 3.22883058 |
| 5 | TBK1 | 3.21061850 |
| 6 | TYK2 | 3.17193762 |
| 7 | MAP4K1 | 3.04429627 |
| 8 | IRAK3 | 3.04090753 |
| 9 | JAK3 | 2.91439052 |
| 10 | KIT | 2.90388003 |
| 11 | IKBKE | 2.71229712 |
| 12 | TXK | 2.26056494 |
| 13 | PBK | 2.23303345 |
| 14 | IKBKB | 2.20259309 |
| 15 | TEC | 2.12755378 |
| 16 | ERN1 | 2.05854392 |
| 17 | PIM2 | 1.99970924 |
| 18 | BTK | 1.93421340 |
| 19 | JAK1 | 1.90157506 |
| 20 | PRPF4B | 1.82603365 |
| 21 | NME2 | 1.80351041 |
| 22 | SYK | 1.77519080 |
| 23 | ZAP70 | 1.56182457 |
| 24 | TESK2 | 1.54314508 |
| 25 | MAP3K13 | 1.54231786 |
| 26 | CSF1R | 1.51823042 |
| 27 | MAP3K3 | 1.51141262 |
| 28 | TNK2 | 1.46763095 |
| 29 | MATK | 1.41805181 |
| 30 | NEK9 | 1.40357780 |
| 31 | TAOK3 | 1.39626602 |
| 32 | CHUK | 1.39349496 |
| 33 | TGFBR2 | 1.38486910 |
| 34 | MST1R | 1.37412406 |
| 35 | MST4 | 1.31789646 |
| 36 | LYN | 1.31077463 |
| 37 | TAOK1 | 1.25559208 |
| 38 | MAP2K3 | 1.22758697 |
| 39 | LCK | 1.22717050 |
| 40 | HCK | 1.21768540 |
| 41 | CSK | 1.21399512 |
| 42 | ITK | 1.17439232 |
| 43 | MAP3K1 | 1.17169681 |
| 44 | STK10 | 1.15479747 |
| 45 | PIM1 | 1.12452615 |
| 46 | RPS6KA4 | 1.11093933 |
| 47 | JAK2 | 1.06581616 |
| 48 | CLK1 | 1.06062084 |
| 49 | EIF2AK2 | 1.02711859 |
| 50 | FLT3 | 0.97825173 |
| 51 | FES | 0.97047542 |
| 52 | TAOK2 | 0.95775910 |
| 53 | FGFR3 | 0.93995397 |
| 54 | CDK19 | 0.92312735 |
| 55 | ACVR1B | 0.91364680 |
| 56 | STK4 | 0.88664873 |
| 57 | FGFR4 | 0.87640587 |
| 58 | TRPM7 | 0.76994765 |
| 59 | FGR | 0.76558649 |
| 60 | EPHB1 | 0.75564480 |
| 61 | PRKCD | 0.74111148 |
| 62 | CDC42BPA | 0.72080154 |
| 63 | GRK7 | 0.71460527 |
| 64 | MAP3K12 | 0.71426988 |
| 65 | LRRK2 | 0.70682008 |
| 66 | KSR2 | 0.69602755 |
| 67 | BMPR2 | 0.69563854 |
| 68 | YES1 | 0.66765426 |
| 69 | PDPK1 | 0.65002034 |
| 70 | IRAK2 | 0.64666518 |
| 71 | PRKG2 | 0.64557116 |
| 72 | GRK6 | 0.62329963 |
| 73 | SIK3 | 0.58688936 |
| 74 | ABL2 | 0.58182516 |
| 75 | MARK3 | 0.58131179 |
| 76 | MAP3K5 | 0.57898036 |
| 77 | ABL1 | 0.57772681 |
| 78 | MAP3K2 | 0.57232822 |
| 79 | MAP3K6 | 0.55265869 |
| 80 | MAPK7 | 0.49537857 |
| 81 | EGFR | 0.49264564 |
| 82 | NLK | 0.48985688 |
| 83 | BMX | 0.46845368 |
| 84 | PIK3CG | 0.45198064 |
| 85 | STK24 | 0.44172182 |
| 86 | MAP3K10 | 0.43687656 |
| 87 | PTK6 | 0.42037376 |
| 88 | RPS6KA6 | 0.41096863 |
| 89 | PRKCQ | 0.40318025 |
| 90 | ADRBK2 | 0.39763291 |
| 91 | MAP2K6 | 0.39378688 |
| 92 | MAPK12 | 0.39206274 |
| 93 | RIPK1 | 0.38438165 |
| 94 | MAPKAPK2 | 0.37932380 |
| 95 | SIK2 | 0.37767170 |
| 96 | HIPK2 | 0.36768138 |
| 97 | MOS | 0.36633884 |
| 98 | MAP3K11 | 0.35663437 |
| 99 | EPHA3 | 0.34339792 |
| 100 | TGFBR1 | 0.34108460 |
| 101 | CDK6 | 0.33837119 |
| 102 | CAMKK2 | 0.33372989 |
| 103 | DYRK1B | 0.32953139 |
| 104 | MAPK11 | 0.32119126 |
| 105 | IRAK1 | 0.31986971 |
| 106 | NUAK1 | 0.31586080 |
| 107 | PTK2B | 0.30899626 |
| 108 | PIK3CA | 0.30615359 |
| 109 | PRKD2 | 0.30039747 |
| 110 | MAPK4 | 0.29405152 |
| 111 | PDK1 | 0.29144512 |
| 112 | EIF2AK3 | 0.28757338 |
| 113 | FRK | 0.28133807 |
| 114 | MUSK | 0.28083106 |
| 115 | RPS6KC1 | 0.26876427 |
| 116 | RPS6KL1 | 0.26876427 |
| 117 | MARK2 | 0.26434573 |
| 118 | KDR | 0.26381203 |
| 119 | IGF1R | 0.25863278 |
| 120 | EIF2AK1 | 0.25109716 |
| 121 | FYN | 0.24958373 |
| 122 | SCYL2 | 0.24744438 |
| 123 | DDR2 | 0.23832169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.41435971 |
| 2 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.75822147 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.71702014 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.68536120 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67631130 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66584894 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53879025 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.51357047 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.45271276 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.41904995 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.35721899 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.30687975 |
| 13 | * Legionellosis_Homo sapiens_hsa05134 | 2.24487507 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.24288416 |
| 15 | * Pertussis_Homo sapiens_hsa05133 | 2.21845893 |
| 16 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.13337107 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.02837691 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 2.02462963 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.02327551 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.96798766 |
| 21 | * Influenza A_Homo sapiens_hsa05164 | 1.91547219 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.86107005 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.84763568 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72390136 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.66209839 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.65270271 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62125036 |
| 28 | * Salmonella infection_Homo sapiens_hsa05132 | 1.59307511 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55142392 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52198393 |
| 31 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.49865975 |
| 32 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.47818182 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46394864 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.44406670 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.43931079 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34966484 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.34497740 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32761515 |
| 39 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.31353515 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.30682743 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.27296719 |
| 42 | Shigellosis_Homo sapiens_hsa05131 | 1.23173091 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21652470 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.19461837 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17698045 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.16667161 |
| 47 | Hepatitis C_Homo sapiens_hsa05160 | 1.13436402 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02129273 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01512237 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00280194 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99388559 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98800945 |
| 53 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88968961 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79735357 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79147210 |
| 56 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.78133653 |
| 57 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73288481 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68517151 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.66845875 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.63365044 |
| 61 | Platelet activation_Homo sapiens_hsa04611 | 0.62215648 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.59782152 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58867884 |
| 64 | Ribosome_Homo sapiens_hsa03010 | 0.56078216 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.52608086 |
| 66 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51138853 |
| 67 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49558324 |
| 68 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49541572 |
| 69 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48662101 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48058811 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.47665931 |
| 72 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47509693 |
| 73 | Endocytosis_Homo sapiens_hsa04144 | 0.46017064 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45474533 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45450855 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44095900 |
| 77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43719820 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43512641 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42243898 |
| 80 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41937727 |
| 81 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40658310 |
| 82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40153715 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37845415 |
| 84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.37388877 |
| 85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37047306 |
| 86 | Proteasome_Homo sapiens_hsa03050 | 0.35690192 |
| 87 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34912082 |
| 88 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33507138 |
| 89 | DNA replication_Homo sapiens_hsa03030 | 0.32918175 |
| 90 | Base excision repair_Homo sapiens_hsa03410 | 0.32723667 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31066199 |
| 92 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30365932 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29807644 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29771343 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28857360 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27363375 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25261433 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25193836 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22251998 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21306720 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.20703485 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20205935 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.19716287 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19482886 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19319087 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19172227 |
| 107 | Insulin resistance_Homo sapiens_hsa04931 | 0.18582735 |
| 108 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18479041 |
| 109 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18408952 |
| 110 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.18129038 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17976495 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.17892207 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17481235 |
| 114 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.17026962 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.12940378 |
| 116 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.12423838 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.11941433 |
| 118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.11335017 |
| 119 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.10883434 |

